Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuangteng Qinglin Pian
- Development stage
- Unknown
- Lead developer
- Guangzhou Ouhua Pharmaceutical Biotechnology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shuangteng Qinglin Pian is a Traditional Chinese Medicine (TCM) tablet developed by Guangzhou Ouhua Pharmaceutical Biotechnology. It is classified as a Class 1.1 innovative Chinese medicine in China, having received marketing approval from the NMPA in late 2021. The formulation is primarily indicated for the treatment of nongonococcal urethritis and cervicitis, specifically those caused by *Chlamydia trachomatis* and *Ureaplasma urealyticum* (associated with damp-heat downward infusion syndrome in TCM). The drug is composed of herbal extracts, including *Lonicera japonica* (Ren Dong Teng) and *Clematis armandii* (Chuan Mu Tong), which are traditionally used to clear heat, resolve dampness, and relieve strangury. Clinical studies have demonstrated its efficacy in reducing symptoms such as urinary frequency, urgency, and pain, while exhibiting a favorable safety profile.
- Brand names
- Shuangteng Qinglin Pian
- Other names
- Shuangteng Qinglin Tablets双藤清淋片
02
Targets
Chlamydia trachomatis
Beyond the preview
Go deeper on Shuangteng Qinglin Pian.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuangteng Qinglin Pian.